We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-12.43%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$73.9B
AUM Growth
-$12.4B
(-14%)
Cap. Flow
-$7.83B
Cap. Flow
% of AUM
-10.58%
Top 10 Holdings %
Top 10 Hldgs %
21.74%
Holding
2,664
New
311
Increased
910
Reduced
656
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$788M |
| 2 |
Union Pacific
UNP
|
+$641M |
| 3 |
Icon
ICLR
|
+$463M |
| 4 |
Wells Fargo
WFC
|
+$310M |
| 5 |
CSX Corp
CSX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$599M |
| 2 |
Intercontinental Exchange
ICE
|
+$280M |
| 3 |
PepsiCo
PEP
|
+$246M |
| 4 |
FedEx
FDX
|
+$242M |
| 5 |
Colgate-Palmolive
CL
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.51% |
| 2 | Healthcare | 14.98% |
| 3 | Financials | 13.27% |
| 4 | Industrials | 10.94% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
ADC Therapeutics
ADCT
$136M
| $127K | ﹤0.01% |
+16,098
| New | +$152K |
|
1202
AngioDynamics
ANGO
$622M
| $127K | ﹤0.01% |
6,582
+1,518
| +30% | +$31.1K |
|
1203
Black Hills Corp
BKH
$5.46B
| $127K | ﹤0.01% |
+1,749
| New | +$131K |
|
1204
Descartes Systems
DSGX
$6.57B
| $127K | ﹤0.01% |
2,055
+1,102
| +116% | +$68.8K |
|
1205
ICF International
ICFI
$1.54B
| $127K | ﹤0.01% |
+1,340
| New | +$130K |
|
1206
Yelp
YELP
$1.41B
| $127K | ﹤0.01% |
4,577
-8,002
| -64% | -$249K |
|
|
TBRG
1207
DELISTED
TruBridge
TBRG
| $127K | ﹤0.01% |
3,997
+2,470
| +162% | +$79.9K |
|
1208
John B. Sanfilippo & Son
JBSS
$996M
| $126K | ﹤0.01% |
1,747
+608
| +53% | +$46.5K |
|
1209
Mitek Systems
MITK
$774M
| $126K | ﹤0.01% |
13,643
-10,959
| -45% | -$117K |
|
1210
RLI Corp
RLI
$5.77B
| $126K | ﹤0.01% |
2,168
-15,686
| -88% | -$899K |
|
1211
Rapid7
RPD
$726M
| $126K | ﹤0.01% |
1,892
-1,722
| -48% | -$142K |
|
|
MNRL
1212
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $126K | ﹤0.01% |
5,126
+2,029
| +66% | +$55.9K |
|
1213
Diodes
DIOD
$3.93B
| $125K | ﹤0.01% |
1,945
+477
| +32% | +$34.8K |
|
1214
i3 Verticals
IIIV
$439M
| $125K | ﹤0.01% |
5,007
-1,877
| -27% | -$47.3K |
|
1215
Ironwood Pharmaceuticals
IRWD
$683M
| $125K | ﹤0.01% |
10,900
+4,630
| +74% | +$54.5K |
|
1216
Helios Technologies
HLIO
$2.72B
| $124K | ﹤0.01% |
1,877
+630
| +51% | +$43.7K |
|
1217
Xencor
XNCR
$1.47B
| $124K | ﹤0.01% |
4,565
+80
| +2% | +$1.97K |
|
1218
Essent Group
ESNT
$6.13B
| $123K | ﹤0.01% |
3,172
+1,504
| +90% | +$61.4K |
|
1219
GitLab
GTLB
$6.11B
| $123K | ﹤0.01% |
2,332
+1,465
| +169% | +$68.1K |
|
1220
PagerDuty
PD
$865M
| $123K | ﹤0.01% |
4,967
-4,513
| -48% | -$124K |
|
1221
Covenant Logistics
CVLG
$900M
| $122K | ﹤0.01% |
9,786
| – | – |
|
1222
Donnelley Financial Solutions
DFIN
$1.22B
| $122K | ﹤0.01% |
4,185
-141,103
| -97% | -$4.19M |
|
1223
LCI Industries
LCII
$2.61B
| $122K | ﹤0.01% |
1,097
+668
| +156% | +$73K |
|
1224
Mesa Laboratories
MLAB
$574M
| $122K | ﹤0.01% |
603
-580
| -49% | -$127K |
|
1225
Phibro Animal Health
PAHC
$1.46B
| $122K | ﹤0.01% |
+6,424
| New | +$122K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Lazard Asset Management held 2,664 positions worth $73.9B, down 14% from $86.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $7.83B in Q2 2022, closing 240 positions and reducing 656 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Aspen Technology Inc worth $74.1M.
- Lazard Asset Management's largest Q2 2022 buy was Aspen Technology Inc: 403,325 shares worth $74.1M.
- Lazard Asset Management added most to Norfolk Southern in Q2 2022, an estimated $788M increase.
- Lazard Asset Management's biggest Q2 2022 reduction was Medtronic, cutting an estimated $599M.
- Lazard Asset Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $156M.
- Lazard Asset Management's ten largest holdings make up 22% of its $73.9B portfolio in Q2 2022.
- Lazard Asset Management opened 311 new positions and closed 240 in Q2 2022.
- Lazard Asset Management's portfolio value fell 14% quarter-over-quarter to $73.9B.
Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.